Cargando…
Cell-Based Therapies for Stroke: Promising Solution or Dead End? Mesenchymal Stem Cells and Comorbidities in Preclinical Stroke Research
Stroke is a major health problem worldwide. It has been estimated that 90% of the population attributable risk of stroke is due to risk factors such as aging, hypertension, hyperglycemia, diabetes mellitus and obesity, among others. However, most animal models of stroke use predominantly healthy and...
Autores principales: | Laso-García, Fernando, Diekhorst, Luke, Gómez-de Frutos, Mari Carmen, Otero-Ortega, Laura, Fuentes, Blanca, Ruiz-Ares, Gerardo, Díez-Tejedor, Exuperio, Gutiérrez-Fernández, María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467162/ https://www.ncbi.nlm.nih.gov/pubmed/31024426 http://dx.doi.org/10.3389/fneur.2019.00332 |
Ejemplares similares
-
The Role of Ultrasound as a Diagnostic and Therapeutic Tool in Experimental Animal Models of Stroke: A Review
por: Gómez-de Frutos, Mari Carmen, et al.
Publicado: (2021) -
Intravenous delivery of adipose tissue-derived mesenchymal stem cells improves brain repair in hyperglycemic stroke rats
por: Gómez-de Frutos, Mari Carmen, et al.
Publicado: (2019) -
B-Mode Ultrasound, a Reliable Tool for Monitoring Experimental Intracerebral Hemorrhage
por: Gómez-de Frutos, Mari Carmen, et al.
Publicado: (2021) -
Low dose of extracellular vesicles identified that promote recovery after ischemic stroke
por: Otero-Ortega, Laura, et al.
Publicado: (2020) -
White Matter Repair After Extracellular Vesicles Administration in an Experimental Animal Model of Subcortical Stroke
por: Otero-Ortega, Laura, et al.
Publicado: (2017)